Successful treatment of “accelerated” chronic lymphocytic leukemia with single agent ibrutinib: A report of two cases.

“Accelerated” chronic lymphocytic leukemia/small lymphocytic lymphoma (A-CLL) is a rare histological variant of CLL/SLL, which tends to exhibit an aggressive clinical behavior compared to CLL. Due to the rarity of A-CLL (<1% of all cases), the optimal management remains ill-defined. We report two...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, John, Jang, Albert, Vegel, Andrew, Hajja, Yasmin, Mouawad, Yara, Baghian, Ali, Berbari, Bachir, Schmid, Janet L., Socola, Francisco, Safah, Hana, Saba, Nakhle S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144065/
https://www.ncbi.nlm.nih.gov/pubmed/34040961
http://dx.doi.org/10.1016/j.lrr.2021.100247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144065/
https://www.ncbi.nlm.nih.gov/pubmed/34040961
http://dx.doi.org/10.1016/j.lrr.2021.100247

Ejemplares similares